Kank-a Liquid
NDC Package 10157-9477-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Kank-a (benzocaine) liquids is to assure formation of a long-lasting film coating, dry affected area and apply medication undiluted with applicatorallow a few seconds for coating to formuse up to 4 times daily, or as directed by a dentist or doctorchildren under 12 years of age should be supervised in the use of this product children under 2 years of age: consult a dentist or doctor. This formulation utilizes a liquid delivery system. Marketed by Blistex Inc., this product is identified by NDC 10157-9477 and is authorized under FDA application M022.

Identification & Billing

NDC Package Code
10157-9477-1
Package Description
9.75 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
10157-9477
11-Digit Billing Format
10157947701
RxNorm Crosswalk
  • RxCUI: 308657 - benzocaine 20 % Mucous Membrane Topical Solution
  • RxCUI: 308657 - benzocaine 200 MG/ML Mucous Membrane Topical Solution

Clinical Specifications

Proprietary Name
Kank-a Mouth Pain
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Buccal - Administration directed toward the cheek, generally from within the mouth.
Active Ingredient(s)
BENZOCAINE 200 mg/mL
Pharmacologic Class
Usage Information
To assure formation of a long-lasting film coating, dry affected area and apply medication undiluted with applicatorallow a few seconds for coating to formuse up to 4 times daily, or as directed by a dentist or doctorchildren under 12 years of age should be supervised in the use of this product children under 2 years of age: consult a dentist or doctor

Regulatory & Marketing

Labeler Name
Blistex Inc.
Product Type
Human Otc Drug
FDA Application #
M022
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-01-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10157-9477-1 identifies a specific commercial package of 9.75 ml in 1 bottle, with applicator of Kank-a Mouth Pain, a human over the counter drug labeled by Blistex Inc.. This liquid is formulated for buccal use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Blistex Inc. on December 01, 2011. The current certification is valid through December 31, 2026.

How is this Blistex Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10157947701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
10157-9477-1
11-Digit CMS (5-4-2)
10157-9477-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.